Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Moderna

This page shows the latest Moderna news and features for those working in and with pharma, biotech and healthcare.

Moderna vaccine given to first UK recipient in Wales

Moderna vaccine given to first UK recipient in Wales

Elle Taylor from Ammanford, a 24-year-old unpaid carer, was the first to receive the Moderna vaccine today. ... The results from this trial showed that the Moderna vaccine has 94% efficacy against the virus and 100% efficacy against severe disease.

Latest news

More from news
Approximately 43 fully matching, plus 104 partially matching documents found.

Latest Intelligence

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    So far the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University vaccines have all received approval in the UK and other countries for the very disease that put all these changes into

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Moderna was the first group to test a vaccine in humans, using its mRNA platform to enter the clinic in record time. ... Moderna thinks its vaccine could be available to healthcare professionals as early as the autumn, but the accepted timeline for

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    At the front of the race is Cambridge, Massachusetts-based biotech company Moderna, which dosed the first patient in the US in March with its COVID-19 vaccine candidate. ... To win approval for public use, a larger phase 2 trial is need, which Moderna

  • Deal Watch September 2016 Deal Watch September 2016

    Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up. ... up. Turning to the battle against the Zika virus, BARDA announced three more grants for vaccine development to Takeda (up to $312m), Moderna [up to

  • Deal Watch June 2016 Deal Watch June 2016

    Apart from the $200m upfront cash payment to Moderna, there were no other financials disclosed. ... licence. 230. Moderna Therapeutics/ Merck &Co. mRNA-based personalised cancer vaccines; exclusive for Keytruda combinations (discovery).

More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Clinical trials and the diversity principle Clinical trials and the diversity principle

    The following month, it happened again. Cambridge, Massachusetts-based Moderna said it had slowed enrolment in its phase 3 COVID-19 vaccine trial to ensure they were getting a representative population. ... Moderna effectively sacrificed potential sales,

  • Mistrust in medical research: a patient perspective

    15]. In fact, Moderna slowed down recruitment for its COVID-19 vaccine trial specifically to address a shortfall in recruitment from ethnically diverse populations for an illness that has been shown

  • Is the world ready for a COVID-19 vaccine? Is the world ready for a COVID-19 vaccine?

    Since then, other good news has followed, with collaborations, including Moderna and AstraZeneca, publishing similarly positive results. ... Since this initial announcement, other good news in vaccine development has followed, with companies and

  • Hanover Communications Hanover Communications

    Since then, other good news has followed, with collaborations, including Moderna and AstraZeneca, publishing similarly positive results.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Quick links

Infographics

Multimedia